Leukemic and lymphomatous meningitis: Incidence, Prognosis and treatment

Journal of Neuro-Oncology

Volumn 75, Issue 1, 2005, Pages 71-83

  Chamberlain, Marc C ^a   Nolan, Craig ^b   Abrey, Lauren E ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Leukemic meningitis; Lymphomatous meningitis

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIEMETIC AGENT; CANNABINOID; CYTARABINE; DEXAMPHETAMINE; FOLIC ACID; MEGESTROL ACETATE; METHOTREXATE; MODAFINIL; NARCOTIC AGENT; PSYCHOSTIMULANT AGENT; STEROID; THIOTEPA; TRICYCLIC ANTIDEPRESSANT AGENT; TUMOR MARKER;

AIDS RELATED COMPLEX; ANOREXIA; ANTINEOPLASTIC ACTIVITY; BACTERIAL MENINGITIS; BRAIN EDEMA; BRAIN RADIOGRAPHY; BRAIN SURGERY; CANCER CONTROL; CANCER GRADING; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CARCINOMATOUS MENINGITIS; CATHETER INFECTION; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID FLOW; CHEMOTHERAPY INDUCED EMESIS; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG MEGADOSE; HIGH RISK PATIENT; HUMAN; LEUKEMIA; LEUKOENCEPHALOPATHY; MULTIMODALITY CANCER THERAPY; MYELOGRAPHY; NEUROTOXICITY; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; REVIEW; RISK ASSESSMENT; SEIZURE; SOMNOLENCE; SPINE RADIOGRAPHY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TREATMENT PLANNING; WEIGHT REDUCTION;

HUMANS; INCIDENCE; LEUKEMIA, LYMPHOCYTIC; LEUKEMIC INFILTRATION; MENINGES; MENINGITIS, ASEPTIC; PROGNOSIS; RISK FACTORS;

EID: 27644539384     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-004-8100-y     Document Type: Review

References (100)

1. LM DeAngelis 1998 Current diagnosis and treatment of leptomeningeal metastasis J Neuro Oncol 38 245-252 10.1023/A:1005956925637
2. JG Kaplan TG DeSouza A Farkash B Shafran D Pack F Rehman J Fuks R Portenoy 1990 Leptomeningeal metastases: Comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias J Neuro Oncol 9 225-229
3. RJ Oostenbrugge Van A Twijnstra 1999 Presenting features and value of diagnostic procedures in leptomeningeal metastases Neurology 53 382-385 10430430
4. Surapaneni UR, Cortes JE, Thomas D et al.: Central Nervous System Relapse in Adults with Acute Lymphoblastic Leukemia. Cancer 94(3): 2002.
5. C Haioun C Besson E Lepage et al. 2000 Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: A GELA study on 974 patients Ann Oncol 11 685-690 10.1023/A:1008394827806 10942056
6. A Hollender S Kvaloy O Nome et al. 2002 Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: A risk model Ann Oncol 13 1099-1107 10.1093/annonc/mdf175 12176790
7. HM Kantarijian S O'Brien TL. Swmith et al. 2000 Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult a cute lymphocytic leukemia J Clin Oncol 18 547-561 10653870
8. HM Kantarjian RS Walters TL Smith et al. 1988 Identification of risk groups for development of central nervous system leukemia in adults with acutelymphocytic leukemia Blood 72 1784-1789 3052630
9. PC Bishop WH Wilson D Pearson J Janik ES Jaffe PC Elwood 1999 CNS involvement in primary mediastinal large B-cell lymphoma J Clin Oncol 17 2479-2485 10561312
10. L Recht DJ Straus C Cirrincione HT Thaler JB Posner 1988 Central nervous system metastases from non-Hodgkin's lymphoma: Treatment and prophylaxis Am J Med 84 425-435 10.1016/0002-9343(88)90262-8 3348245
11. EL Bollen RE Brouwer S Hamers J Hermans M Kluin SU Sankatsing RV A-Tjak MV Charvat JC Kluin-Nelemans 1997 Central nervous system relapse in non-Hodgkin's lymphoma: A single-center study of 532 patients Arch Neurol 54 854-859 9236574
12. J Ersboll HB Schultz BL Thomsen N Keiding NI Nissen 1985 Meningeal involvement in non-Hodgkin's lymphoma: Symptoms, incidence, risk factors and treatment Scand J Haematol 35 487-496 4089528
13. JP Litam F Cabanillas TL Smith GP Bodey EJ. Freireich 1979 Central nervous system relapse in malignant lymphomas: Risk factors and implications for prophylaxis Blood 54 1249-1257 508936
14. R Liang E Chiu SL Loke 1990 Secondary central nervous system involvement by non-Hodgkin's lymphoma: The risk factors Hematol Oncol 8 141-145 2373491
15. K Besien Van CS Ha S Murphy P McLaughlin A Rodriguez K Amin A Forman J Romaguera F Hagemeister A Younes C Bachier A Sarris KS Sobocinski JD Cox F Cabanillas 1998 Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma Blood 91 1178-1184 9454747
16. MC Chamberlain PA Kormanik 1997 Non-AIDS related lymphomatous meningitis: Combined modality therapy Neurology 49 1728-1731 9409381
17. LJ Levitt DM Dawson DS Rosenthal et al. 1980 CNS involvement in the non-Hodgkin's lymphoma Cancer 45 545-552 6986199
18. O'Neill BP.: Neurologic Complications of Hodgkin's disease and the non-Hodgkin's lymphomas: Cancer Neurol Clin Prac 371-384.
19. HH Reiche 2003 Leukemia. In Cancer Neurology in Clinical Practice Humana Press Inc. Totowa, New Jersey 355-369
20. Recht L, Mrugala M. Neurologic complications of hematologic neoplasms. Neurologic Clinics, W.B. Saunders Company. 2003, Vol. 21, No. 1. pp 87-105.
21. RW Wolk SR Masse R Conklin EJ. Freireich 1974 The incidence of central nervous system leukemia in adults with acute leukemia Cancer 33 863 4521890
22. DJ Stewart MJ Keating KB McCredie et al. 1981 Natural history of central nervous system acute leukemia in adults Cancer 47 184-196 7459807
23. RJ Meyer PP Ferreira J. Cuttner et al. 1980 Central nervous system involvement at presentation in acute granulocytic leukemia. a prospective cytocentrifuge study Am J Med 68 691-694 10.1016/ 0002-9343(80)90255-7 6929653
24. D Thomas J Cortes FJ Giles et al. 2001 The modified hyper-CBAD regimen in newly diagnosed adult acute lymphoblastic leukemia (ALL) Blood 98 suppl. 1 590a
25. J Cortes 2001 Central nervous system involvement in adult acute lymphocytic leukemia Hematol Oncol Clin North Am. 15 145-162 10.1016/ S0889-8588(05)70203-3 11253605
26. J Cash KM Fehir MS Pollack 1987 Meningeal involvement in early stage chronic lymphocytic leukemia Cancer 59 798-800 3802037
27. SC Cramer JA Glaspy JT Efird DN Louis 1996 Chronic lymphocytic leukemia and the central nervous system: A clinical and pathological study Neurology 46 19-25 8559372
28. JH Bower JE Hammack SK McDonnell A Tefferi 1997 The neurologic complications of B-cell chronic lymphocytic leukemia Neurology 48 407-412 9040730
29. LE Abrey J Yahalom DeAngelis 2000 Treatment for primary CNS lymphoma: the next step J Clin Oncol 18 3144-3150 10963643
30. U Herrilinger M Schabet W Brugger RD Kortmann W Kuker et al. 2002 German Cancer Society Neuro-Oncology Working Group NOA-03 Multicenter Trial of Single-Agent High-Dose Methotrexate for Primary CNS Lymphoma Ann Neurol 51 247-252 10.1002/ana.10102 11835382
31. BJ Fisher W Sieferheld C Schultz L DeAngelis SC Schold W Curran 2001 Secondary analysis of RTOG 9310: An intergroup phase II combined modality treatment of primary central nervous system lymphoma with chemotherapy and hyperfractionated radiotherapy Int J Rad Oncol Biol Phy 51 3 Suppl 1 166-177 10.1016/S0360-3016(01)02125-3
32. HM Kantarjian T Smith E Estey et al. 1992 Prognostic significance of elevated serum beta 2-microglobulin levels in acute lymphocytic leukemia Am J Med. 93 599-604 10.1016/0002-9343(92)90191-D 1466355
33. F Ravandi J Cortes Z Estrov et al. 2002 CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemia Leuk Res 26 643-649 10.1016/S0145-2126(01)00188-6 12008081
34. GM Mavlight SE Stuckey FF Cabanillas et al. 1980 Diagnosis of leukemia or lymphoma in the central nervous system by beta 2-microglobulin determination N Engl J Med 303 718-722 6157089
35. MC Chamberlain 1998 Leptomeningeal metastases: A review of evaluation and treatment J Neuro Oncol 37 271-84 10.1023/A:1005976926058
36. M Chamberlain 1996 leptomeningeal metastases In: V Levin (ed) Cancer in the Nervous System Churchill Livingstone New York 282-290
37. W Wasserstrom J Glass J Posner 1982 Diagnosis and treatment of leptomeningeal metastases from solid tumors experience with 90 patients Cancer 49 759-772 6895713
38. SA Grossman MJ Krabak 1999 Leptomeningeal carcinomatosis Cancer Treat Rev 25 2 103-119 10.1053/ctrv.1999.0119 10395835
39. J Murray F Greco S Wolff et al. 1983 Neoplastic meningitis; marked variations of cerebrospinal fluid composition in the absence of extradural block Am J Med 75 289-294 10.1016/0002-9343(83)91207-X 6881181
40. B Burger M Zimmermann G Mann et al. 2003 Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: Significance of low leukocyte counts with blasts or traumatic lumbar puncture J Clini Oncol 21 2 184-188 10.1200/JCO.2003.04.096
41. WR Wasserstrom MK Schwartz M Fleisher et al. 1981 Cerebrospinal fluid biochemical markers in central nervous system tumors: A review Ann Clin Lab Sci 11 3 239-251 6166240
42. AP Zanten Van A Twijnstra AA Hart et al. 1986 Cerebrospinal fluid lactate dehydrogenase activities in patients with central nervous system metastases Clin Chim Acta 161 3 259-268 10.1016/0009-8981(86)90009-4 3802533
43. GG Klee RD Tallman JR Goellner et al. 1986 Elevation of carcinoembryonic antigen in cerebrospinal fluid among patients with meningeal carcinomatosis Mayo Clin Proc 61 1 9-13 3510343
44. A Twijnstra AP Zanten van AA Hart et al. 1987 Serial lumbar and ventricle cerebrospinal fluid lactate dehydrogenase activities in patients with leptomeningeal metastases from solid and haematological tumours J Neurol Neurosurg Psychiatry 50 3 313-320 3559613
45. A Twijnstra DV Ongerboer AP Zanten van et al. 1989 Serial lumbar and ventricular cerebrospinal fluid biochemical marker measurements in patients with leptomeningeal metastases from solid and hematological tumors J Neuro Oncol 7 1 57-63 10.1007/BF00149379
46. G Stockhammer W Poewe S Burgstaller et al. 2000 Vascular endothelial growth factor in CSF: A biological marker for carcinomatous meningitis Neurology 54 8 1670-1676 10762512
47. MC Chamberlain 1998 Cytologically negative carcinomatous meningitis: usefulness of CSF biochemical markers Neurology 50 4 1173-1175 9566421
48. JA Garson HB Coakham JT Kemshead et al. 1985 The role of monoclonal antibodies in brain tumour diagnosis and cerebrospinal fluid (CSF) cytology J Neuro Oncol 3 2 165-171
49. A Hovestadt SC Henzen-Logmans CJ Vecht 1990 Immunohistochemical analysis of the cerebrospinal fluid for carcinomatous and lymphomatous leptomeningitis Br J Cancer 62 4 653-654 2223585 62 4 653-654 2223585
50. W Boogerd TM Vroom P Heerde van et al. 1988 CSF cytology versus immunocytochemistry in meningeal carcinomatosis J Neurol Neurosurg Psychiatry 51 1 142-145 2832546
51. MJ Kersten LM Evers PL Dellemijn et al. 1996 Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies Blood 87 1985-1999 8634448
52. GM Jeffery CM Frampton HM Legge DN Hart 1990 Cerebrospinal fluid B2-microglobulin levels in meningeal involvement by malignancy Pathology 22 20-23 2194155
53. RJ Oostenbrugge Van AH Hopman FC Ramaekers et al. 1998 In situ hybridization: A possible diagnostic aid in leptomeningeal metastasis J Neuro Oncol 38 2-3 127-133 10.1023/A:1005926624303
54. ES Cibas MG Malkin JB Posner et al. 1987 Detection of DNA abnormalities by flow cytometry in cells from cerebrospinal fluid Am J Clin Pathol 88 5 570-577 3673940
55. RJ Oostenbrugge Van AH Hopman JW Arends et al. 1998 The value of interphase cytogenetics in cytology for the diagnosis of leptomeningeal metastases Neurology 51 3 906-908 9748058
56. CH Rhodes MJ Glantz L Glantz et al 1996 A comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis Cancer 77 3 543-548 10.1002/ (SICI)1097-0142(19960201)77:3<543::AID-CNCR17>3.0.CO;2-4 8630963
57. CH Rhodes MJ Glantz L Glantz A Lekos GD Sorenson C Honsinger NB Levy 1996 A comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis Cancer 77 543-548 10.1002/ (SICI)1097-0142(19960201)77:3<543::AID-CNCR17>3.0.CO;2-4 8630963
58. S Biesterfeld B Bernhard S Bamborschke et al. 1993 DNA single cell cytometry in lymphocytic pleocytosis of the cerebrospinal fluid Acta Neuropathol (Berl) 86 5 428-432
59. TM Cheng BP O'Neill BW Scheithauer et al. 1994 Chronic meningitis: The role of meningeal or cortical biopsy Neurosurgery 34 4 590-595 8008155
60. J Glass M Melamed N Chernik et al 1979 Malignant cells in cerebrospinal fluid (CSF) the meaning of a positive CSF cytology Neurology 29 1369-1375 573381
61. M Chamberlain A Sandy G. Press 1990 Leptomeningeal metastasis a comparison of gadolinium-enhanced MR and contrast-enhanced CT of the brain Neurology 40 435-438
62. G Sze S Soletsky R Bronen et al. 1989 MR imaging of the cranial meninges with emphasis on contrast enhancements and meningeal carcinomatosis AJNR 10 965-975 2505542
63. DA Collie RJ Sellar JP Steyn RE Cull 1999 The diagnostic yield of magnetic resonance imaging (MRI) of the brain and spine requested by general practitioners: Comparison with hospital clinicians Br J Gen Pract 49 559-561 10621993
64. JM Gomori N Heching T. Siegal 1998 Leptomeningeal metastases: Evaluation by gadolinium enhanced spinal magnetic resonance imaging J Neuro Oncol 36 55-60 10.1023/A:1005783507544
65. MC Chamberlain 1995 Comparative spine imaging in leptomeningeal metastases Neuro-Oncol 23 233-238 10.1007/BF01059954
66. K Kim S Ho P Weinberg et al. 1982 Spinal leptomeningeal infiltration by systemic cancer myelographic features AJR 139 361-365 6979894
67. E Kramer S Rafto R Packer et al. 1991 Comparison of myelography with CT follow-up versus gadolinium MRI for subarachnoid metastatic disease in children Neurology 41 46-50
68. M Chamberlain J Corey-Bloom 1991 Leptomeningeal metastases indium-DTPA CSF flow studies Neurology 41 1765-1769 1944906
69. MC Chamberlain P Kormanik 1996 Prognostic significance of indium-DTPA CSF flow studies Neurology 46 6 1674-1677 8649568
70. JA Paulus GM Bos B Lowenberg MJ Bent Van Den 1998 Treatment results and the prognosis in patients with localization of non-Hodgkin's-lymphoma in the central nervous system Ned Tijdschr Geneeskd 142 3 2196-2200 9864481
71. F Bokstein A Lossos IS Lossos T Siegal 2002 Central nervous system relapse of systemic non-Hodgkin's lymphoma: Results of treatment based on high-dose methotrexate combination chemotherapy Leuk Lymphoma 43 587-593 10.1080/10428190290012092 12002763
72. T Philip C Guglielmi A Hagenbeek R Somers H Lelie Van der D Bron P Sonneveld C Gisselbrecht JY Cahn JL Harousseau et al. 1995 Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma N Engl J Med 333 1540-1545 10.1056/NEJM199512073332305 7477169
73. CD Williams R Pearce G Taghipour ES Green T Philip AH Goldstone 1994 Autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma and CNS involvement: Those transplanted with active CNS disease have a poor outcome - a report by the European Bone Marrow Transplant Lymphoma Registry J Clin Oncol 12 2415-2422 7964958
74. JC Alvarnas RS Negrin SJ Horning WW Hu GD Long JR Schriber K Stockerl-Goldstein K Tierney R Wong KG Blume NJ Chao 2000 High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma Biol Blood Marrow Transplant 6 352-358 10905773
75. MJ Glantz S LaFollette KA Jaeckle W Shapiro L Swinnen JR Rozental S Phuphanich LR Rogers JC Gutheil T Batchelor D Lyter M Chamberlain BL Maria C Schiffer R Bashir D Thomas W Cowpens SB Howell 1999 Randomized trial of a slow release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis J Clin Oncol 17 3110-3116 10506606
76. M Chamberlain L Dirr 1993 Involved field radiotherapy and intra-ommaya methotrexate/ara-C in patients with AIDS-related lymphomatous meningitis J Clin Onc 11 1978-1984
77. MC Chamberlain P Kormanik M Glantz 1998 Recurrent primary central nervous system lymphoma complicated by lymphomatous meningitis Oncol Rep 5 521-523 9468593
78. S Yoshida K Morii M Watanabe T Saito 2000 Characteristic features of malignant lymphoma with central nervous system involvement Surg Neurol 53 163-167 10.1016/S0090-3019(99)00186-X 10713195
79. MC Chamberlain PA Kormanik 1997 Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases J Neurosurg 87 694-699 9347977
80. MC Chamberlain PA Kormanik 1997 Prognostic significance of coexistent bulky metastatic central nervous system disease in patients with leptomeningeal metastases Arch Neurol 54 1364-1368 9362983
81. R Blasberg C Patlak J Fenstermacher 1975 Intrathecal chemotherapy brain tissue profiles after ventriculo-cisternal perfusion Pharm Exp Ther 195 73-83
82. IT Magrath TB Haddy MA Adde 1996 Treatment of patients with high-grade non-Hodgkin's lymphomas and central nervous system involvement: Is radiation an essential component of therapy Leuk Lymphoma 21 99-105 8907276
83. F Balis D Poplack 1989 Central nervous system pharmacology of antileukemic drugs Amer J Pediatr Hemat/Oncol 11 74-86
84. J Collins 1983 Pharmacokinetics of intraventricular administration J Neuro-Oncol 1 283-291 10.1007/BF00165710
85. T Siegal A Lassos MR Pfeffer 1994 Leptomeningeal metastases: Analysis of 31 patients with sustained off-therapy response following combined-modality therapy Neurology 44 1463-1469 8058150
86. W Boogerd AAM Hart Sande Van der et al 1991 Meningeal carcinomatosis breast cancer Prognostic factors and influence of treatment. Cancer 67 1685-1695
87. L Giannone F Greco J Hainsworth 1986 Combination intraventricular chemotherapy for meningeal neoplasia J Clin Oncol 4 68-73 3079822
88. R Hitchens D Bell R Woods et al. 1987 A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis J Clin Oncol 5 1655-1662 3309199
89. SA Grossman DM Finkelstein JC Ruckdeschel et al. 1993 Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis J Clin Oncol 11 561-569 8445432
90. W Shapiro D Young B Mehta 1975 Methotrexate distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections N Engl J Med 293 161-166 806016
91. CS Rabkin F Yellin 1994 Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1 J Natl Cancer Inst 16; 86 16 1711-1716
92. A Cingolani R Gastaldi L Fassone F Pierconti ML Giancola M Martini A Luca De A Ammassari C Mazzone E Pescarmona G Gaidano LM Larocca A Antinori 2000 Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin's lymphomas J Clin Oncol 18 3325-3330 11013271
93. BO Taiwo 2000 AIDS-related primary CNS lymphoma: A brief review AIDS Read 10 486-491 10967810
94. LM DeAngelis E Wong M Rosenblum H Furneaux 1992 Epstein-Barr virus in acquired immune deficiency syndrome (AIDS) and non-AIDS primary central nervous system lymphoma Cancer 70 1607-1611 1325277
95. J Desai RJ Mitnick DH Henry J Llena JA Sparano 1999 Patterns of central nervous system recurrence in patients with systemic human immunodeficiency virus-associated non-Hodgkin lymphoma Cancer 86 1840-1847 10.1002/ (SICI)1097-0142(19991101)86:9<1840::AID-CNCR28>3.0.CO;2-C 10547559
96. MC Chamberlain PA Kormanik 1999 AIDS-related central nervous system lymphomas J Neuro Oncol 43 269-276 10.1023/A:1006262720665
97. LE Raez P Patel L Feun A Restrepo WA Raub Jr. PA Cassileth 1998 Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL) Crit Rev Oncol 9 199-208
98. JD Goldstein DW Dickson FG Moser AD Hirschfeld K Freeman JF Llena B Kaplan L Davis 1991 Primary central nervous system lymphoma in acquired immune deficiency syndrome A clinical and pathologic study with results of treatment with radiation. Cancer 67 2756-2765
99. C Balmaceda JJ Gaynor M Sun JT Gluck LM DeAngelis 1995 Leptomeningeal tumor in primary central nervous system lymphoma: Recognition, significance, and implications Ann Neurol 38 202-209 10.1002/ ana.410380212 7654067
100. MC Chamberlain 2003 Neoplastic meningitis-related encephalopathy: prognostic significance. American Academy of Neurology, Honolulu, Hawaii, March 29-April 5, 2003 Neurology 60 5 A17-A18 10.1159/000070452